Workflow
辅料及原料药
icon
Search documents
红日药业:12月12日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-12-12 12:13
每经AI快讯,红日药业(SZ 300026,收盘价:3.62元)12月12日晚间发布公告称,公司第九届第四次 董事会会议于2025年12月12日在天津市武清开发区创业总部基地B01号楼公司会议室以现场加通讯表决 方式召开。会议审议了《关于修订 <公司章程> 的议案》等文件。 2024年1至12月份,红日药业的营业收入构成为:中药配方颗粒及饮片占比46.15%,成品药占比 24.72%,医疗器械占比19.39%,辅料及原料药占比8.33%,其他行业占比1.42%。 截至发稿,红日药业市值为109亿元。 每经头条(nbdtoutiao)——实施城乡居民增收计划、降准降息等工具灵活高效运用、增加普通高中学 位……深度解读中央经济工作会议 (记者 王晓波) ...
红日药业:股东姚小青计划减持不超过约4694万股
Mei Ri Jing Ji Xin Wen· 2025-11-06 11:53
Group 1 - The core point of the news is that Hongri Pharmaceutical announced a share reduction plan by major shareholders and senior management, indicating potential changes in ownership structure [1] - Shareholder Yao Xiaoqing, holding approximately 300 million shares (10% of total shares), plans to reduce holdings by up to 46.94 million shares (1.5624% of total shares) within three months after the announcement [1] - Senior management members Chen Ruiqiang and Zhang Kun plan to reduce their holdings by up to 170,000 shares (0.0056% of total shares) and 230,000 shares (0.0077% of total shares) respectively, also within three months after the announcement [1] Group 2 - For the fiscal year 2024, Hongri Pharmaceutical's revenue composition is as follows: Traditional Chinese medicine formula granules and decoction pieces account for 46.15%, finished drugs 24.72%, medical devices 19.39%, excipients and raw materials 8.33%, and other industries 1.42% [2] - As of the latest report, Hongri Pharmaceutical has a market capitalization of 11.4 billion yuan [3]
红日药业:10月27日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-10-28 09:30
Company Overview - Hongri Pharmaceutical (SZ 300026) announced its third board meeting of the ninth session held on October 27, 2025, in Tianjin, where the agenda included the discussion of the 2025 Q3 report [1] - As of the report, Hongri Pharmaceutical has a market capitalization of 11.4 billion yuan [1] Revenue Composition - For the year 2024, the revenue composition of Hongri Pharmaceutical is as follows: - Traditional Chinese medicine formula granules and decoction pieces account for 46.15% - Finished drugs account for 24.72% - Medical devices account for 19.39% - Auxiliary materials and raw materials account for 8.33% - Other industries account for 1.42% [1]